Učitavanje...
Is It the Twilight of BACE1 Inhibitors?
β-secretase (BACE1) has been regarded as a prime target for the development of amyloid beta (Aβ) lowering drugs in the therapy of Alzheimer´s disease (AD). Although the enzyme was discovered in 1991 and helped to formulate the Aβ hypothesis as one of the very important features of AD etiopathogenesi...
Spremljeno u:
| Izdano u: | Curr Neuropharmacol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Science Publishers
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7903497/ https://ncbi.nlm.nih.gov/pubmed/32359337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X18666200503023323 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|